Access the precision of whole genome analysis in your clinical trial.

We work alongside research teams to generate multiple classifiers—so you can gain a deeper understanding of your clinical trial results.

Comprehensive assessment of the whole genome makes your data base future proof for re-analysis when new information comes to light.


InsightsQ4 is an end-to-end service that collects, integrates and analyses whole genome and clinical data.

It allows you to overcome the limitations of a panel and access the full picture through whole genome sequencing, analysis and reporting.

Read more about InsightsQ4

Biomarker support

Work with us to unlock genomics to support biomarker discovery, or to identify possible companion diagnostics for your therapy.

Possible classifiers include:

  • comparing patients who have adverse events to those who do not
  • poor responses versus good responses
  • side effects versus response.


Where targeted panels only reveal a fraction of the picture, whole genome analysis allows you to determine the complete range of genome variants including:

  • single nucleotide variant and indels
  • copy number changes and rearrangements
  • telomere length.
Our expert partner

We partner with Max Kelson, an analytics and software engineering agency, to bring genomics and artificial intelligence together powerfully.

Read more about our work together.